Vtex
NYSE:VTEXSoftware - Application
-$0.02 today
- Market cap
- $588.03M
- Beta
- 1.04
- P/E (TTM)
- 26.2
- EPS (TTM)
- $0.14
Volume 1.00M
Average 1.33M
VTEX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
VtexNYSE: VTEX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2026 research & development of $17.05M rose 14.7% year over year, behind the +18.3% change in trailing-twelve-month research & development. Sequentially, it rose 1.0% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.
Context
- Research & development amounted to 26.6% of revenue in FY2025, up 2.9 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +14.7% toward the trailing-twelve-month pace of +18.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 63.89M USD
- Year-over-year change
- +19.2%
- 4-year CAGR
- +9.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 63.89M | +19.2% |
| FY2024 | 2024-12-31 | 53.62M | -10.8% |
| FY2023 | 2023-12-31 | 60.12M | +5.1% |
| FY2022 | 2022-12-31 | 57.21M | +26.6% |
| FY2021 | 2021-12-31 | 45.19M | — |
Research & Development vs competitors
How VTEX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +18.3% is the 2nd highest of 9, against a peer median of -5.9%.
- Research & development amounts to 26.7% of revenue for VTEX, versus a peer median of 7.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥1.01B CNY | +28.6% | -1.5% | 7.9% | |
| LTM Mar 2026 | $68.47M USD | +0.1% | -2.2% | 19.5% | |
| LTM Mar 2026 | $66.07M USD | +18.3% | +3.8% | 26.7% | |
| LTM Mar 2026 | $57.52M USD | -15.0% | +12.8% | 16.9% | |
| LTM Mar 2026 | $52.17M USD | +11.2% | +26.5% | 20.8% | |
| LTM Mar 2026 | $40.48M USD | +2.6% | -10.5% | 7.2% | |
| LTM Mar 2026 | $34.74M USD | -11.9% | -38.0% | 27.2% | |
| LTM Mar 2026 | $2.65M USD | — | — | 2.8% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding VTEX) | — | -5.9% | -1.8% | 7.9% | |
Competitors are the stored peer set for VTEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 125.77M | 157.62M | 201.52M | 226.71M | 240.52M |
| Cost of Revenue | 49.59M | 52.83M | 60.95M | 59.42M | 54.18M |
| Gross Profit | 76.18M | 104.79M | 140.57M | 167.29M | 186.34M |
| Gross Margin | 60.6% | 66.5% | 69.8% | 73.8% | 77.5% |
| Research & Development | 45.19M | 57.21M | 60.12M | 53.62M | 63.89M |
| Selling, General & Admin | 95.41M | 96.15M | 93.13M | 102.29M | 102.64M |
| Operating Expenses | 142.11M | 154.71M | 155.17M | 157.19M | 168.23M |
| Depreciation & Amortization | 4.07M | 4.62M | 5.02M | 4.36M | 3.26M |
| EBITDA | (65.12M) | (51.1M) | (4.99M) | 14.4M | 25.75M |
| EBITDA Margin | -51.8% | -32.4% | -2.5% | 6.4% | 10.7% |
| Operating Income | (65.93M) | (49.92M) | (14.6M) | 10.1M | 18.11M |
| Operating Margin | -52.4% | -31.7% | -7.2% | 4.5% | 7.5% |
| Interest Income | 264K | 2.25M | 23.76M | 14.17M | 3.66M |
| Interest Expense | 790K | 733K | 578K | 1.43M | 0 |
| Other Income / Expenses | (4.06M) | (6.53M) | 4.02M | (440K) | 4.37M |
| Income Before Tax | (69.99M) | (56.44M) | (10.59M) | 9.66M | 22.48M |
| Pre-Tax Margin | -55.6% | -35.8% | -5.3% | 4.3% | 9.3% |
| Income Tax Expense | (9.47M) | (4.03M) | 3.11M | (2.33M) | 2.45M |
| Net Income | (60.51M) | (52.42M) | (13.69M) | 12M | 20.01M |
| Net Margin | -48.1% | -33.3% | -6.8% | 5.3% | 8.3% |
| EPS (Basic) | (0.32) | (0.27) | (0.07) | 0.06 | 0.11 |
| EPS (Diluted) | (0.32) | (0.27) | (0.07) | 0.06 | 0.11 |
| Weighted Avg Shares | 191.03M | 190.7M | 186.37M | 185.04M | 185.28M |
| Weighted Avg Shares (Diluted) | 191.03M | 190.7M | 186.37M | 192.33M | 185.28M |
Vtex
NYSE:VTEX
Intrinsic Alpha fair value
Locked
Current Price
$3.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.